Over 20 Major Partners Join HopeLink`s Syndicated Network to Offer the HopeLink Clinical Trial Service
(PR Newswire)...Lustgarten Foundation for Pancreatic Cancer Research National Brain Tumor Foundation; National Breast Cancer Coalition;...- May 14 7:02 AM ET
Posted on: 05/14/2001
"Yahoo - Over 20 Major Partners Join HopeLink's Syndicated Network to Offer the HopeLink Clinical Trial Service"
[ Latest Headlines
News Alerts ]
Monday May 14, 7:02 am Eastern Time
Over 20 Major Partners Join HopeLink's Syndicated Network to Offer the HopeLink Clinical Trial Service
Partner Organizations Signed to Present HopeLink's Syndicated Network Include ALCASE, Cancer Research Foundation of America, Colorectal Cancer Network, Healthcommunities.com, International Myeloma Foundation, National Brain Tumor Foundation, National Multiple Sclerosis Society, National Prostate Cancer Coalition, Oncology Nursing Society, The Breast Cancer Fund, US TOO! and 0thers
MENLO PARK, Calif., May 14 /PRNewswire/ -- HopeLink Corporation today
announced that more than 20 organizations including healthcare companies,
non-profit organizations, patient advocacy groups, research cooperatives, and
voluntary health societies have partnered with HopeLink to offer its
groundbreaking clinical trial service to cancer patients and their advocates.
HopeLink is building a syndicated network and Clinical Trial Service that are
designed to improve the clinical trial development and enrollment processes.
HopeLink's service has been available since December 2000 and currently lists
The company expects to offer clinical trials in other
disease states in the future.
"The quality, breadth and enthusiasm of our syndicated network partners
endorses our approach to facilitating clinical trial awareness worldwide,"
said Jim Messemer, president and CEO, HopeLink.
"When people are diagnosed
with cancer, many turn to Internet search engines to quickly locate websites
that have disease specific information.
Our syndicated network is
specifically designed to provide critical clinical trial information to the
websites patients and their advocates are visiting most often."
The more than 20 organizations that will be presenting HopeLink's Clinical
Trial Service on their websites include:
Alliance for Lung Cancer Advocacy,
Support and Education (ALCASE); American Foundation for Urologic Disease;
American-Italian Cancer Foundation; Annie Appleseed Project; Cancer Research
Foundation of America; Cherubim Foundation; Colorectal Cancer Network; Florida
Cancer Education Network; Healthcommunities.com's OncologyChannel.com;
HealthFrontier.com; HealthLinks.net; International Myeloma Foundation; Kidney
Cancer Association; Lung Cancer Online; Lustgarten Foundation for Pancreatic
Cancer Research; National Brain Tumor Foundation; National Breast Cancer
Coalition; National Multiple Sclerosis Society; National Prostate Cancer
Coalition; Oncology Nursing Society; The Breast Cancer Fund; and US TOO!
view the live Clinical Trial Service on HopeLink's syndicated network, visit
the following url: www.hopelink.com/about_service/find
The HopeLink Clinical Trial Service is a free, accessible and searchable
directory of clinical trials that instantly provides patients, advocates,
research professionals and healthcare organizations with the latest
information on drug therapies under development, including enrollment
information and eligibility requirements.
HopeLink also offers its customers
and partners a number of workflow, reporting and content management tools to
facilitate clinical trial participation.
"HopeLink's service allows us to provide patients with easy access to
clinical trials," said Rob Tufel, MSW, MPH, and director of patient services,
National Brain Tumor Foundation.
"Patients are now able to find all the
information they need through our website without having to sort through the
often overwhelming amount of information on the Internet."
"We are excited to incorporate HopeLink's services on OncologyChannel.com
as it provides a much needed resource for patients and their families to
instantly learn about the latest clinical trials," said Dr. Stanley J.
Swierzewski III, founder and CEO, Healthcommunities.com.
"Having as much
information as possible about diagnosis and treatment options is very
important to our audience.
Our partnership with HopeLink helps us meet our
goal of providing trustworthy medical information online."
"HopeLink's service has become one of the most used areas on our website,"
said Mike Katz, vice president, International Myeloma Foundation.
accurate information saves lives and HopeLink is helping us provide this
information to myeloma patients around the world."
HopeLink does not recruit or enroll patients in clinical trials, accept
advertising revenue, or collect per-patient compensation or "bounties."
company leverages its syndicated network of partner websites to help patients
and their advocates self-select for clinical trials.
include industry sponsors and investigative sites that pay service fees in
exchange for enhanced clinical trial listings and process management tools.
"We believe that a self-referral model that empowers individuals will
emerge as a major channel for patient enrollment in addition to the current
flow from physician referrals," said Larry Hausner, vice president of
strategic partnerships, HopeLink.
"Our unique partnership strategy allows
HopeLink to have enormous reach and touch millions of people seeking
potentially lifesaving treatment options."
"We selected HopeLink as our partner because the company is
patient-centered and has a policy not to accept per-patient bounties or resell
patient lists to investigators," said Priscilla Savary, executive director,
Colorectal Cancer Network.
"HopeLink's service empowers our patients by
allowing them to self-select for a clinical trial and is especially appealing
because it allows us to offer this benefit with a minimal amount of effort on
"HopeLink's search capabilities are easy-to-use, fast, and accurate," said
Elizabeth G. Gomez, RN, MSN, AOCN, and editor of ONS Online, the official
website of the Oncology Nursing Society.
"We selected the HopeLink Clinical
Trial Service because it enhanced our award-winning clinical trials content
and we didn't have to spend precious resources to build it ourselves."
"The National Prostate Cancer Coalition is committed to ending the
devastating impact prostate cancer has on American men and their families.
realize our mission, we must equip survivors and advocates across the country
with the most useful and effective tools," said Skip Lockwood, director of
programs and senior editor, National Prostate Cancer Coalition.
Clinical Trial Service is just what we have been looking for to help patients
and families find potentially lifesaving treatments while advancing the
research needed to find a cure for cancer."
"As a cancer advocacy group, one of the goals of the Cancer Research
Foundation of America is to educate the public about the value of clinical
trials and help individuals understand that trials are the only way to
translate the amazing breakthroughs made in laboratories around the country to
new, more effective treatments for patients," said Carolyn Aldige, President
and Founder, Cancer Research Foundation of America.
"Our partnership with
HopeLink brings us one step closer to realizing this goal."
Organizations interested in presenting HopeLink's Clinical Trial Service
on their websites and becoming a syndicated network partner can email
Clinical trial sponsors interested in listing trials on
HopeLink's service may also email email@example.com.
About the HopeLink Clinical Trial Service
The HopeLink Clinical Trial Service is a hosted, web-based application
that facilitates patient enrollment and creates process efficiencies for
organizations that sponsor and conduct clinical trials.
This turnkey software
solution, launched in December 2000, can be tailored to ensure successful
deployment and integration of new and existing processes.
The service is
presented through a syndicated network of numerous partner websites.
Headquartered in Menlo Park, CA, HopeLink is a privately held software
company that provides products and services to improve the clinical trial
development and enrollment processes.
HopeLink's solutions aim to not only
increase clinical trial awareness and exposure, but also to create
efficiencies through standardization and automation of time-consuming
The company's investors and management team are comprised of
experienced executives from the healthcare, high technology, and non-profit
HopeLink can be reached at www.hopelink.com .
MAKE YOUR OPINION COUNT - Click Here
Email this story - Most-emailed articles - Most-viewed articles
Copyright © 2001 Yahoo! Inc. All rights reserved.
Terms of Service
Copyright © 2001 PR
All rights reserved.
Republication or redistribution of PRNewswire content
is expressly prohibited
without the prior written consent of PRNewswire.
PRNewswire shall not be liable for any errors or delays
in the content,
or for any actions taken in reliance
Questions or Comments?
Click HERE to return to brain tumor news headlines